Pfizer’s Biosimilars Grow By A Tenth

As First-Half Sales Of Sterile Injectables Slip By A Similar Proportion

Pfizer logo
Pfizer has seen biosimilars grow and sterile injectables decline in the first half of 2022 • Source: Alamy

More from Biosimilars

More from Products